Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the impact of the oral contraceptive YASMIN
(containing: drospirenone 3 mg/ethinyl estradiol 30 mcg) in comparison with the oral
contraceptive MICROGYNON (containing: levonorgestrel 150 mcg/ethinyl estradiol 30mcg) on
factors of blood coagulation and fibrinolysis in female subjects
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
Treatments:
Drospirenone and ethinyl estradiol combination Ethinyl Estradiol-Norgestrel Combination Ethinyl estradiol, levonorgestrel drug combination Hemostatics